There is exciting news in the field of Alzheimer’s disease (AD) research with the advent of a new blood test which can determine the presence of a key marker, brain amyloidosis, the buildup of amyloid proteins in the brain, as well as other blood proteins known to be associated with AD. Early detection of the disease can have implications in terms of benefitting from any current and new treatments, joining research trials underway and taking advantage earlier of any support services available.
The blood test can be administered after a clinical examination uncovers symptoms of Alzheimerhttp://www.alz.org/’s disease including cognitive impairment such as dementia. This new blood test is safe, affordable and easy to administer in a variety of settings. Currently, the only definitive tests for the presence of AD either have major drawbacks associated with them or can only be done post mortem. The first method of extracting cerebrospinal fluid requires an invasive spinal tap and carries the risk of nerve damage. The second is a PET scan testing for amyloids in the brain exposes the patient to radiation, is not usually covered by insurance and few centers have the technology. Autopsies can reveal brain beta amyloid proteins in the brain, a hallmark sign of AD, but, obviously, has no benefit to the sufferer at that time.
This new test also has the benefit of reducing the stress of not knowing for the patient and their loved ones. An important byproduct of the test is enhancing the integrity of research by ensuring that only true AD patients are included in any treatment trials which currently have an error rate of about 25% of non-AD patient inclusion.
Receiving a diagnosis of Alzheimer’s disease is naturally extremely stressful to all concerned. Anticipating and planning for the eventual outcome of the disease is not easy, but David York Home Healthcare Agency can help. When home healthcare becomes necessary, David York Agency provides skilled home health aide services for the elderly and infirm in their home. We would be happy to discuss your case with you. Please call us at (718) 376-7755 or visit our website. Please like us on Facebook or follow us on Twitter, Google+ or LinkedIn.